BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23289836)

  • 21. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
    Yerubandi V; Chin BB; Sosa JA; Hoang JK
    AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
    Targe M; Basu S
    J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the burden of incidental FDG-avid thyroid nodules: New consensus statement.
    Perros P
    Clin Endocrinol (Oxf); 2024 May; 100(5):486-487. PubMed ID: 36942402
    [No Abstract]   [Full Text] [Related]  

  • 24. ¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
    Marzola MC; Rubello D
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):132-5. PubMed ID: 22498183
    [No Abstract]   [Full Text] [Related]  

  • 25. FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
    Lin EC
    Clin Nucl Med; 2007 Feb; 32(2):152-3. PubMed ID: 17242576
    [No Abstract]   [Full Text] [Related]  

  • 26. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
    Prichard RS; Cotter M; Evoy D; Gibbons D; Collins C; McDermott E; Skehan S
    Ir Med J; 2011 Jun; 104(6):177-9. PubMed ID: 22111394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
    Makis W; Hickeson M; Novales-Diaz JA
    Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
    [No Abstract]   [Full Text] [Related]  

  • 28. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R; Mullan D; Yap BK; Gandhi A
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET for a thyroid MALT lymphoma.
    Lee CJ; Hsu CH; Tai CJ; Lin SE
    Acta Oncol; 2008; 47(6):1165-7. PubMed ID: 18770065
    [No Abstract]   [Full Text] [Related]  

  • 30. FDG-PET detected thyroid incidentalomas: need for further investigation?
    Are C; Hsu JF; Schoder H; Shah JP; Larson SM; Shaha AR
    Ann Surg Oncol; 2007 Jan; 14(1):239-47. PubMed ID: 17024553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of positron emission tomography (PET) in the management of patients with thyroid cancer.
    Robbins RJ; Larson SM
    Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):1047-59. PubMed ID: 19041831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A surgical perspective on positron emission tomography.
    Gulec SA
    J Surg Oncol; 2007 May; 95(6):443-6. PubMed ID: 17221861
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Yoshida A; Borkar S; Singh B; Ghossein RA; Schöder H
    J Clin Oncol; 2008 Dec; 26(35):5817-9. PubMed ID: 19001338
    [No Abstract]   [Full Text] [Related]  

  • 34. Current role of radionuclide imaging in differentiated thyroid cancer.
    Wong KT; Choi FP; Lee YY; Ahuja AT
    Cancer Imaging; 2008 Sep; 8(1):159-62. PubMed ID: 18818134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
    Low SC; Sinha AK; Sundram FX
    Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
    Mehta A; Muthukrishnan A
    Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
    London K; Lin M
    Ann Surg Oncol; 2011 Jan; 18(1):291. PubMed ID: 20505997
    [No Abstract]   [Full Text] [Related]  

  • 38. Investigation of thyroid, head, and neck cancers with PET.
    Zhuang H; Kumar R; Mandel S; Alavi A
    Radiol Clin North Am; 2004 Nov; 42(6):1101-11, viii. PubMed ID: 15488560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
    Strobel K; Steinert HC; Bhure U; Koma AY; Gassmann N; Stöckli SJ
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):813. PubMed ID: 17225114
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary squamous cell carcinoma of the thyroid on FDG PET/CT.
    Cai L; Chen Y; Huang Z; Wu J
    Clin Nucl Med; 2014 Nov; 39(11):1014-6. PubMed ID: 24999700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.